Literature DB >> 8420962

Control of protein traffic between distinct plasma membrane domains. Requirement for a novel 108,000 protein in the fusion of transcytotic vesicles with the apical plasma membrane.

E Sztul1, M Colombo, P Stahl, R Samanta.   

Abstract

We have developed a cell-free system that reconstitutes the last step in transcytosis, i.e. the fusion of transcytotic transport vesicles with the apical plasma membrane (PM). Subcellular fractions containing transcytotic vesicles (the donor) or apical PM (the acceptor) were prepared from rat liver by sucrose density centrifugation. Fusion between the donor and acceptor fractions was measured by the conversion of the 120,000 transmembrane form of the polymeric IgA receptor (pIgA-R), an endogenous protein of transcytotic vesicles, to a processed fragment by a protease endogenous to the apical PM. Fusion occurred only at 37 degrees C and was critically dependent on the presence of ATP and cytosol. Fusion was inhibited by treating the in vitro fusion reaction with N-ethylmaleimide or by adding antibodies against N-ethylmaleimide-sensitive factor (NSF). We have previously identified a specific transcytotic vesicle-associated protein (TAP) and here show that TAP exists in both cytosolic and membrane-associated pools. Because of its exclusive interaction with transcytotic vesicles, we tested the involvement of TAP in distinct fusion processes. Removal of TAP inhibited fusion in an in vitro transcytotic fusion reaction but had no inhibitory effect in an in vitro endosome-endosome fusion system or in an in vitro intra-Golgi transport reaction. We propose that TAP represents part of the molecular machinery specifically involved in targeting and/or fusion of transcytotic vesicles with the apical PM.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8420962

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

1.  The EF-hand Ca(2+)-binding protein p22 associates with microtubules in an N-myristoylation-dependent manner.

Authors:  S Timm; B Titus; K Bernd; M Barroso
Journal:  Mol Biol Cell       Date:  1999-10       Impact factor: 4.138

2.  The role of the tethering proteins p115 and GM130 in transport through the Golgi apparatus in vivo.

Authors:  J Seemann; E J Jokitalo; G Warren
Journal:  Mol Biol Cell       Date:  2000-02       Impact factor: 4.138

3.  Quantitative phosphoproteomics of vasopressin-sensitive renal cells: regulation of aquaporin-2 phosphorylation at two sites.

Authors:  Jason D Hoffert; Trairak Pisitkun; Guanghui Wang; Rong-Fong Shen; Mark A Knepper
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-25       Impact factor: 11.205

Review 4.  Molecular mechanisms in exocytosis.

Authors:  J M Edwardson; S J Marciniak
Journal:  J Membr Biol       Date:  1995-07       Impact factor: 1.843

Review 5.  Regulated exocytosis.

Authors:  R D Burgoyne; A Morgan
Journal:  Biochem J       Date:  1993-07-15       Impact factor: 3.857

6.  Transcytosis in the continuous endothelium of the myocardial microvasculature is inhibited by N-ethylmaleimide.

Authors:  D Predescu; R Horvat; S Predescu; G E Palade
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

7.  Endothelial transcytotic machinery involves supramolecular protein-lipid complexes.

Authors:  S A Predescu; D N Predescu; G E Palade
Journal:  Mol Biol Cell       Date:  2001-04       Impact factor: 4.138

8.  Putative fusogenic activity of NSF is restricted to a lipid mixture whose coalescence is also triggered by other factors.

Authors:  B Brügger; W Nickel; T Weber; F Parlati; J A McNew; J E Rothman; T Söllner
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

9.  Homotypic vacuole fusion requires Sec17p (yeast alpha-SNAP) and Sec18p (yeast NSF).

Authors:  A Haas; W Wickner
Journal:  EMBO J       Date:  1996-07-01       Impact factor: 11.598

10.  Multiple N-ethylmaleimide-sensitive components are required for endosomal vesicle fusion.

Authors:  L Rodriguez; C J Stirling; P G Woodman
Journal:  Mol Biol Cell       Date:  1994-07       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.